bloomberg report noted johnson johnson cut costs faces generic competition best selling prescription drug antipsychotic risperdal generated billion last year phew good thing invega son risperdal market save day preliminary read probably bogus research suggesting works better seroquel treating schizophrenia see recent post understand skepticism regarding latest results invega entering crowded market abilify seroquel zyprexa generic risperidone geodon etc i think going fare particularly well unless pretty darned impressive marketing entirely question i humbly suggest taking piece pfizer geodon campaign